These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9746523)

  • 1. Epibatidine activates muscle acetylcholine receptors with unique site selectivity.
    Prince RJ; Sine SM
    Biophys J; 1998 Oct; 75(4):1817-27. PubMed ID: 9746523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epibatidine binds with unique site and state selectivity to muscle nicotinic acetylcholine receptors.
    Prince RJ; Sine SM
    J Biol Chem; 1998 Apr; 273(14):7843-9. PubMed ID: 9525877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for epibatidine selectivity at desensitized nicotinic receptors.
    Pennington RA; Gao F; Sine SM; Prince RJ
    Mol Pharmacol; 2005 Jan; 67(1):123-31. PubMed ID: 15496507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonists binding nicotinic receptors elicit specific channel-opening patterns at αγ and αδ sites.
    Stock P; Ljaschenko D; Heckmann M; Dudel J
    J Physiol; 2014 Jun; 592(12):2501-17. PubMed ID: 24665094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P; Sharples CG; Wonnacott S
    Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
    Gerzanich V; Peng X; Wang F; Wells G; Anand R; Fletcher S; Lindstrom J
    Mol Pharmacol; 1995 Oct; 48(4):774-82. PubMed ID: 7476906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluorophore attached to nicotinic acetylcholine receptor beta M2 detects productive binding of agonist to the alpha delta site.
    Dahan DS; Dibas MI; Petersson EJ; Auyeung VC; Chanda B; Bezanilla F; Dougherty DA; Lester HA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10195-200. PubMed ID: 15218096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity binding of epibatidine to serotonin type 3 receptors.
    Drisdel RC; Sharp D; Henderson T; Hales TG; Green WN
    J Biol Chem; 2008 Apr; 283(15):9659-65. PubMed ID: 17702741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-conotoxin residues that interact at close range with gamma-tyrosine-111 and mutant delta-tyrosine-113 on the Torpedo nicotinic acetylcholine receptor.
    Vélez-Carrasco W; Valdés S; Agresar L; Lettich A; Guerra AY; Hann RM
    Biochemistry; 2004 Oct; 43(39):12700-8. PubMed ID: 15449960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding orientation of epibatidine at α7 nACh receptors.
    Thompson AJ; Metzger S; Lochner M; Ruepp MD
    Neuropharmacology; 2017 Apr; 116():421-428. PubMed ID: 28089847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the alpha subunit on imidacloprid sensitivity of recombinant nicotinic acetylcholine receptors.
    Matsuda K; Buckingham SD; Freeman JC; Squire MD; Baylis HA; Sattelle DB
    Br J Pharmacol; 1998 Feb; 123(3):518-24. PubMed ID: 9504393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonidentity of the alpha-neurotoxin binding sites on the nicotinic acetylcholine receptor revealed by modification in alpha-neurotoxin and receptor structures.
    Ackermann EJ; Taylor P
    Biochemistry; 1997 Oct; 36(42):12836-44. PubMed ID: 9335541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current.
    Alkondon M; Albuquerque EX
    J Pharmacol Exp Ther; 1995 Aug; 274(2):771-82. PubMed ID: 7543571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional differences between neurotransmitter binding sites of muscle acetylcholine receptors.
    Nayak TK; Bruhova I; Chakraborty S; Gupta S; Zheng W; Auerbach A
    Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17660-5. PubMed ID: 25422413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [(3)H]Epibatidine photolabels non-equivalent amino acids in the agonist binding site of Torpedo and alpha4beta2 nicotinic acetylcholine receptors.
    Srivastava S; Hamouda AK; Pandhare A; Duddempudi PK; Sanghvi M; Cohen JB; Blanton MP
    J Biol Chem; 2009 Sep; 284(37):24939-47. PubMed ID: 19620239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dissection of subunit interfaces in the acetylcholine receptor. Identification of residues that determine agonist selectivity.
    Prince RJ; Sine SM
    J Biol Chem; 1996 Oct; 271(42):25770-7. PubMed ID: 8824205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntheses and biological properties of cysteine-reactive epibatidine derivatives.
    Che C; Petit G; Kotzyba-Hibert F; Bertrand S; Bertrand D; Grutter T; Goeldner M
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1001-4. PubMed ID: 12643898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain.
    Houghtling RA; Dávila-García MI; Kellar KJ
    Mol Pharmacol; 1995 Aug; 48(2):280-7. PubMed ID: 7651361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological similarities between native brain and heterologously expressed alpha4beta2 nicotinic receptors.
    Shafaee N; Houng M; Truong A; Viseshakul N; Figl A; Sandhu S; Forsayeth JR; Dwoskin LP; Crooks PA; Cohen BN
    Br J Pharmacol; 1999 Nov; 128(6):1291-9. PubMed ID: 10578144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.